Clinical trial
SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular…
NCT00274105 · Boehringer Ingelheim, Industry · Terminated
Key facts
| NCT number | NCT00274105 |
|---|---|
| Title | SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients |
| Official title | A Double Blind, 2:1 Randomised Monocentre Study to Investigate the Efficacy and Safety of Telmisartan (80 mg qd) Concerning the Amelioration of Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients (SAFE-CRP: Structural Alterations and Function of Endothelium in… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Coronary Arteriosclerosis |
| Intervention type | Drug |
| Interventions | telmisartan, Placebo |
| Enrollment | 22 |
| Start date | Mar 1, 2001 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Jan 10, 2006 |
| Last update posted | Jan 23, 2025 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: